Topics

Companies Related to "MorphoSys MorphoSys Biopharma Announce First Patient Dosed Phase" [Most Relevant Company Matches] - Page: 3 RSS

14:10 EDT 14th October 2019 | BioPortfolio

Here are the most relevant search results for "MorphoSys MorphoSys Biopharma Announce First Patient Dosed Phase" found in our extensive corporate database of over 50,000 company records.

Showing "MorphoSys MorphoSys Biopharma Announce First Patient Dosed Phase" Companies 51–75 of 4,200+

Relevant

Richmond Pharmacology Ltd

Our goal is to deliver full service Early Phase clinical solutions swiftly, efficiently, and to the highest clinical standard. Our integrated set-up is designed to manage your Early Phase study within the controlled environment of Phase I. We compliment this through our out-patient facilities offering flexibility through the Phases in clinical trials.“Richmond Pharmacology is the UK's only Early...


Canopus Biopharma INC

Canopus BioPharma, Inc. (OTCPK:CBIA) is dedicated to providing the safest, most cost effective and efficacious pharmaceutical products and assay methods in the areas of infectious disease, radiation protection, cancer, and addiction. With innovative science, proven research and development leadership, and superior products and compounds, Canopus BioPharma has, since 2001, been committed to bec...

Purdue Biopharma

Purdue Biopharma L.P. is a research-oriented biopharmaceutical company which seeks to benefit patients by providing new treatments for cancer, infectious diseases and disorders of the immune system. As the Discovery Research arm of a growing and successful international Pharmaceutical organization, we are seeking highly motivated professionals to support our expansion in the Princeton, NJ area. ...


China Biopharma

China Biopharma Inc. (Stock Symbol: CBPC.OB) is a fast growing provider of human vaccine products in China. Through its wholly owned subsidiary, China Biopharma Limited, the Company owns the majority interest of Zhejiang Tianyuan Biotech Co., Ltd. The Company's current products consist of human vaccines against influenza (flu), epidemic hemorrhagic fever (HF), and Japanese Encephalitis (JE). With ...

PharmaCord LLC

An independently owned company, PharmaCord provides services to biopharma manufacturers supporting the commercialization of specialty products. The company is the connector between manufacturers, patients, physicians and payors. Solutions drive efficient and rapid therapy initiation and increased patient engagement.

Phase One Medical, L.L.C.

Phase One Medical is a privately held medical device research and development company. The company is focused on early stage development and small part design and manufacture. For more information on Phase One Medical, L.L.C. products and services e-mail the company at info@phase-one.us.

Medizone International

Triatomic Oxygen (O3 or ozone), is the first layer of atmospheric protection interfacing the vastness of the cosmos with Planet Earth. Ozone's healing properties have been known for many years and the use of medical ozone pre-dates WW I. Toxicity was a problem in early medical ozone usage as the drug was produced using compressed air containing nitrogen, rather than medical grade oxygen (O2). The ...

Genor Biopharma

Genor Biopharma is a clinical-stage biopharmaceutical company located in Zhangjiang, Shanghai, China. Genor is focused on the therapeutic areas of oncology and autoimmune diseases. The Company delivers a portfolio of novel therapies built to address unmet medical needs. The Company’s leading product candidates are late stage innovative monoclonal antibodies. Genor maintains state-of-the-art ...

Minnesota Adult and Teen Challenge

The Ramsey County Coalition is hosting a press conference to announce details of its “Not Another Overdose” campaign, which will include prevention events, community messaging and a PSA that will be shown at local movie theaters.

Array BioPharma

Array BioPharma is a drug discovery company inventing new small molecule drugs through the integration of chemistry, biology and informatics. Our experienced scientists use the Array Discovery Platform, our integrated set of drug discovery technologies, to invent novel small molecule drugs in collaboration with leading pharmaceutical and biotechnology companies and to build our own pipeline of pro...

Favrille

We are a biopharmaceutical company focused on the development and commercialization of patient-specific immunotherapies for the treatment of cancer and other diseases of the immune system. We own a proprietary technology that enables us to efficiently develop and manufacture active immunotherapy products designed to stimulate a patient's own immune system to mount a specific and sustained response...

DOR BioPharma

DOR BioPharma, Inc. is a biopharmaceutical company addressing life-threatening side effects of cancer and cancer treatments, serious gastrointestinal diseases and disorders, and biomedical countermeasures. Our lead product, orBec® (oral beclomethasone dipropionate), is a potent, locally-acting corticosteroid being developed for the treatment of gastrointestinal Graft-versus-Host disease (GI GVHD)...

Think Global Awards

The Think Global Awards recognize the achievements of people, projects, brands and companies around the world. Awards events will be held in Europe and the USA to announce the winners.

Phase One Medical

Phase One Medical is a privately held medical device research and development company. The company is focused on early stage device development and small part design and manufacture. For more information on Phase One Medical, L.L.C. products and services e-mail the company at info@phase-one.us or visit the company’s web site at: www.phaseonemedical.co...

Zensights

Zensights is a pharmaceutical vendor management company focused on making the currently complex world of vendor selection easier for the BioPharma manufacturer. Zensights' signature Vendor Analysis Tool analyzes, aggregates, and provides an overall market assessment of the capabilities of third-party vendors that service the bio-tech, pharmaceutical,...

Biologics by McKesson

Biologics by McKesson is an independent specialty pharmacy with over 24 years of experience connecting patients to life-changing medications in oncology and other complex therapeutic areas. Built on the foundation of deep clinical expertise and a high-touch approach to patient care, Biologics by McKesson delivers seamless access and personalized eng...

Probably Relevant

Prime Trials Inc.

Prime Trials Inc. was started in 1998 as CroMedica Prime. At that time the CroMedica Group of Medicines Development Companies wished to develop phase 1 and 2a capabilities to round out there ability to provide complete coverage of all types of human clinical trials from phase 1 through 4. Also, in keeping with CroMedica's philosophy of providing a quality service well grounded in medicine and s...

Synageva BioPharma Corp.

Synageva BioPharma Corp. is dedicated to discovering, developing and commercializing therapies for patients with rare conditions and unmet medical need. The Company has developed a pipeline of novel therapeutics for under-served populations and has assembled a team with a proven record of bringing orphan therapies to patients. Additionally, Synageva is ...

SmartZyme BioPharma, Inc.

SmartZyme BioPharma, Inc. is a New York-based OrbiMed portfolio company that specializes in researching and developing optimized protein, enzyme, and mRNA therapeutics through directed evolution. SmartZyme’s current portfolio includes a next-generation, ultra-accurate, glucose-sensing enzyme that undergoes direct-electron transfer which has been integ...

Landos Biopharma, Inc.

Landos Biopharma, Inc. is an emerging biopharmaceutical company focused on the discovery and development of first-in-class oral therapeutics for patients with autoimmune diseases. Landos’ lead clinical asset, BT-11, is a novel, locally-acting small molecule targeting inflammatory bowel disease (IBD) that is expected to enter clinical testing for Crohn’s...

Can-Fite BioPharma Ltd

CAN-FITE BIOPHARMA LTD is a public company traded on the Tel Aviv Stock Exchange. The Company, which commenced business activity in 2000, was founded by Prof. Pnina Fishman, an investigator from Rabin Medical Center, and patent attorney Dr. Ilan Cohn, a senior partner at Reinhold Cohn Patent Attorneys. Prof. Pnina Fishman serves as the CEO of Can-Fite. The...

Cue Biopharma, Inc.

Cue Biopharma™ (Cue) is an immunotherapy company developing biologics engineered to selectively communicate with disease-relevant T cell subsets to treat cancer and autoimmune disease. Cue biologics have the potential to be highly effective as monotherapies as well as synergistic with existing checkpoint inhibitors, while reducing collateral toxici...

Principia Biopharma Inc.

Principia Biopharma is a privately-held biopharmaceutical company focused on the discovery and development of best-in-class small molecule drugs for autoimmune diseases and cancer. The company uses its proprietary technology, licensed from the University of California San Francisco, to enable a new approach to making small molecules that are potent, safe a...

Lytix Biopharma

CeNeRx BioPharma, Inc.


More From BioPortfolio on "MorphoSys MorphoSys Biopharma Announce First Patient Dosed Phase"

Quick Search

Corporate Database Quicklinks